Clinical Trials Directory

Trials / Conditions / Cholangiocarcinoma of the Gallbladder

Cholangiocarcinoma of the Gallbladder

11 registered clinical trials studyying Cholangiocarcinoma of the Gallbladder.

StatusTrialSponsorPhase
CompletedNal-IRI and 5-FU Compared to 5-FU in Patients With Cholangio- and Gallbladder Carcinoma Previously Treated Wit
NCT03043547
AIO-Studien-gGmbHPhase 2
CompletedCPI-613 in Treating Patients With Advanced or Metastatic Bile Duct Cancer That Cannot Be Removed By Surgery
NCT01766219
Wake Forest University Health SciencesPhase 1 / Phase 2
CompletedGenotype-guided Dosing of mFOLFIRINOX Chemotherapy in Patients With Previously Untreated Advanced Gastrointest
NCT01643499
University of ChicagoPhase 1
TerminatedCediranib Maleate and Combination Chemotherapy in Treating Patients With Advanced Biliary Cancers
NCT01229111
National Cancer Institute (NCI)Phase 2
CompletedEverolimus, Gemcitabine Hydrochloride, and Cisplatin in Treating Patients With Unresectable Solid Tumors Refra
NCT00949949
Mayo ClinicPhase 1
CompletedBevacizumab and Erlotinib Hydrochloride in Treating Patients With Metastatic or Unresectable Biliary Tumors
NCT00356889
National Cancer Institute (NCI)Phase 2
CompletedS0514 Sorafenib in Treating Patients With Unresectable or Metastatic Gallbladder Cancer or Cholangiocarcinoma
NCT00238212
National Cancer Institute (NCI)Phase 2
CompletedErlotinib in Treating Patients With Unresectable Liver, Bile Duct, or Gallbladder Cancer
NCT00033462
National Cancer Institute (NCI)Phase 2
CompletedVaccine Therapy With or Without Sargramostim in Treating Patients With Advanced or Metastatic Cancer
NCT00028496
National Cancer Institute (NCI)Phase 1
TerminatedBMS-247550 in Treating Patients With Liver or Gallbladder Cancer
NCT00023946
National Cancer Institute (NCI)Phase 2
WithdrawnStent Placement With or Without Photodynamic Therapy Using Porfimer Sodium as Palliative Treatment in Treating
NCT00253617
Jonsson Comprehensive Cancer CenterPhase 3